Table 2 Survival time by histology and stage at diagnosis
N | Deaths N (%) | Survival time (months) Median | Survival time (months) Mean [sd] | Follow-up time (months) Mean [sd] | |
|---|---|---|---|---|---|
NSCLC | |||||
Stage I | 39 | 6 (15.4) | - | 36.3 [2.2] | 21.2 [13.1] |
Stage II | 11 | 3 (27.3) | - | 32.1 [3.9] | 21.5 [13.3] |
Stage III | 36 | 17 (47.2) | 16.0 | 18.9 [2.8] | 11.9 [11.4] |
Stage IV | 71 | 44 (62.0) | 4.9 | 10.7 [1.9] | 5.6 [7.9] |
Unknown | 15 | 5 (33.3) | - | 20.1 [4.5] | 10.1 [12.1] |
Total | 172 | 75 (43.6) | 18.0 | 22.8 [1.6] | 11.9 [12.5] |
SCLC | |||||
Limited disease | 7 | 4 (57.1) | 10.9 | 17.0 [3.6] | 12.6 [7.1] |
Extensive disease | 16 | 13 (81.3) | 8.6 | 9.4 [2.5] | 8.4 [9.1] |
Unknown | 3 | 2 (66.7) | 1.1 | 1.3 [0.4] | 1.3 [1.0] |
Total | 26 | 19 (73.1) | 8.9 | 11.8 [2.6] | 8.7 [8.5] |
NCC | |||||
Stage I | 2 | 0 (0.0) | - | - | 36.3 [0.2] |
Stage II | - | - | - | - | - |
Stage III | 4 | 2 (50.0) | - | - | 11.9 [13.6] |
Stage IV | 16 | 11 (68.8) | - | - | 4.8 [8.7] |
Unknown | 12 | 3 (25.0) | - | - | 1.8 [2.1] |
Total | 34 | 16 (47.1) | - | - | 6.4 [10.9] |